Literature DB >> 18727805

Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis.

C M Bébéar1, B de Barbeyrac, S Pereyre, H Renaudin, M Clerc, C Bébéar.   

Abstract

The activity of moxifloxacin was compared with that of other antimicrobial agents against 54 strains of Ureaplasma spp., 54 strains of Mycoplasma hominis, 14 strains of Mycoplasma genitalium, and 44 strains of Chlamydia trachomatis. Moxifloxacin inhibited 90% of all isolates at a concentration </=1 mg/L, being the most active compound against C. trachomatis and sharing the highest activity with garenoxacin and gemifloxacin against mycoplasmas. Moxifloxacin killed the 30 mycoplasma isolates tested at a concentration </=1 mg/L, except those resistant to fluoroquinolone. Thus, moxifloxacin has attracted interest as a potential therapy for mycoplasmal or chlamydial urogenital infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18727805     DOI: 10.1111/j.1469-0691.2008.02027.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  14 in total

1.  Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium.

Authors:  Kaitlin A Tagg; Neisha J Jeoffreys; Deborah L Couldwell; Jennifer A Donald; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

Review 2.  Mycoplasma hominis, a Rare but True Cause of Infective Endocarditis.

Authors:  Amandine Gagneux-Brunon; Florence Grattard; Jerome Morel; Florence Suy; Jean-François Fuzellier; Paul Verhoeven; Celine Cazorla; Claire Guglielminotti; Anne Fresard; Frederic Lucht; Elisabeth Botelho-Nevers
Journal:  J Clin Microbiol       Date:  2015-07-01       Impact factor: 5.948

3.  Mycoplasma genitalium: should we treat and how?

Authors:  Lisa E Manhart; Jennifer M Broad; Matthew R Golden
Journal:  Clin Infect Dis       Date:  2011-12       Impact factor: 9.079

Review 4.  Chlamydia (uncomplicated, genital).

Authors:  Megan Crofts; Paddy Horner
Journal:  BMJ Clin Evid       Date:  2015-04-16

5.  Role of Mycoplasma and ureaplasma species in female lower genital tract infections.

Authors:  Meghan Arvind Patel; Paul Nyirjesy
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

6.  Efficacy of standard therapies against Ureaplasma species and persistence among men with non-gonococcal urethritis enrolled in a randomised controlled trial.

Authors:  Christine M Khosropour; Lisa E Manhart; Catherine W Gillespie; M Sylvan Lowens; Matthew R Golden; Nicole L Jensen; George E Kenny; Patricia A Totten
Journal:  Sex Transm Infect       Date:  2015-01-23       Impact factor: 3.519

7.  Therapeutic Drug Monitoring of Moxifloxacin to Guide Treatment of Mycoplasma hominis Meningitis in an Extremely Preterm Infant.

Authors:  Telford Yeung; Erin Chung; Jennifer Chen; Laura K Erdman; Mina Smiljkovic; Waison Wong; Asaph Rolnitsky; Shaun K Morris; Amr El Shahed; Rudaina Banihani; Ari Bitnun; Christopher Tomlinson
Journal:  J Pediatr Pharmacol Ther       Date:  2021-11-10

8.  Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.

Authors:  Ryoichi Hamasuna; Jørgen Skov Jensen; Yukio Osada
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

9.  Mycoplasma hominis hematoma infection in patient following kidney transplant.

Authors:  Mackenzie A Dolan; Zachary S Elliott; Christopher J Arnold
Journal:  IDCases       Date:  2021-06-12

10.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.